SEC Filings | Sana Biotechnology, Inc

Filing date	Description	Form	View
Apr 26, 2022	Official notification to shareholders of matters to be brought to a vote ("Proxy")	DEF 14A	0001193125-22-118701.pdf 0001193125-22-118701.rtf 0001193125-22-118701.xls View HTML
Apr 28, 2023	Official notification to shareholders of matters to be brought to a vote ("Proxy")	DEF 14A	0001193125-23-123965.pdf 0001193125-23-123965.rtf 0001193125-23-123965.xls View HTML
May 01, 2023	POS EX	POS EX	0001193125-23-130383.pdf 0001193125-23-130383.rtf 0001193125-23-130383.xls View HTML
Mar 15, 2023	POSASR	POSASR	0001193125-23-071344.pdf 0001193125-23-071344.rtf 0001193125-23-071344.xls View HTML
Mar 16, 2023	Post-effective amendment to an S-Type filing	POS AM	0001193125-23-072746.pdf 0001193125-23-072746.rtf 0001193125-23-072746.xls View HTML
May 05, 2021	Quarterly report which provides a continuing view of a company's financial position	10-Q	0001564590-21-024148.pdf 0001564590-21-024148.rtf 0001564590-21-024148.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
Aug 04, 2021	Quarterly report which provides a continuing view of a company's financial position	10-Q	0001564590-21-040861.pdf 0001564590-21-040861.rtf 0001564590-21-040861.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
Nov 08, 2021	Quarterly report which provides a continuing view of a company's financial position	10-Q	0001564590-21-055263.pdf 0001564590-21-055263.rtf 0001564590-21-055263.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
May 10, 2022	Quarterly report which provides a continuing view of a company's financial position	10-Q	0001564590-22-019299.pdf 0001564590-22-019299.rtf 0001564590-22-019299.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
Aug 04, 2022	Quarterly report which provides a continuing view of a company's financial position	10-Q	0001564590-22-028036.pdf 0001564590-22-028036.rtf 0001564590-22-028036.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML

Data provided by Kaleidoscope.